Clinical Trial Imaging Market is anticipated to grow at a CAGR of 6.57% from 2021 to 2027 globally – Axiom MRC

The factors such as the increasing number of contract research companies, the rapidly increasing elderly population with chronic diseases, and the continuous investments in the research and development activities are majorly driving the growth of the clinical trial imaging market. Similarly, the other supportive factors include rapid growth in the pharmaceutical and biotechnology industries, along with rapidly evolving healthcare industries across the world, growing market for the medical services, along with increasing number of the clinical trials owing to the current corona virus pandemic, development of the innovative contrast agents, radiopharmaceuticals, imaging modalities, and the molecular probes are likely to expand the growth of the clinical trial imaging market over the forecast period.

New York, October 2021: Axiom Market Research & Consulting™ added a report on clinical trial imaging market which includes study on product and services, modality, end user, and geography. The clinical trial imaging market was projected to grow at a CAGR of 6.57% for the forecast period 2021 to 2027. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the clinical trial imaging market.

The report analyses the clinical trial imaging market based on product and services, modality, end user and geography. By product and services, the clinical trial imaging market is segmented into services and software, and services include clinical trial design and consultation services, operational imaging services, project and data management, reading and analytical services, system and technology support services. By modality, the clinical trial imaging market is segmented into compound tomography, echocardiography, magnetic resonance imaging, positron emission tomography, ultrasound, X-Ray, and other modalities. By end user, the clinical trial imaging market is segmented into academic and government research institutes, biotechnology companies, contract research organizations, medical device manufacturers, pharmaceutical companies, and other end users. By geography, the clinical trial imaging market is studied in the regions including North America, Europe, Asia Pacific, and Rest of the World.

Get sample PDF Report @ https://www.axiommrc.com/request-for-sample/report?=10398

The key players in the clinical trial imaging market are Bioclinica, Inc, Parexel International Corporation, Icon PLC, Biomedical Systems Corporation, Biotelemetry, Inc, Cardiovascular Imaging Technologies, LLC, Intrinsic Imaging LLC, Ixico PLC, Radiant Sage LLC and Worldcare Clinical, LLC among others.

Regional Trends of Clinical Trial Imaging Market

Based on the geography, the clinical trial imaging market is studied in the countries of North America, Europe, Asia Pacific, and Rest of the World. The region of North America held the highest market share of the clinical trial imaging market, and it is also expected to dominate the market during the forecast period. The factors like increasing research and development investments in the field of the clinical research, along with vast presence of the leading outsourcing companies in the region, increasing number of the chronic diseases across North America, increasing healthcare expenditure from the private and public entities, and rise in the number of pharmaceutical and biotechnology companies are responsible for the growth of the clinical trial imaging market in the region.

Clinical Trial Imaging Market Segmentation Highlights

• The services segment has dominated the clinical trial imaging market in the past few years. The project and data management segment has expected to dominate the market under the segment
• Computed tomography modality segment has dominated the clinical trial imaging market in 2020. The factors such as increasing significance of the computed tomography technology owing to the benefits of computed tomography in the screenings for the cancer, injuries are responsible to the growth of the clinical trial imaging market
• Under the end user segment, the medical device manufacturers segment is expected to witness fast growth in the clinical trial imaging market during the forecast period. The factors like raopid growth in the global medical devices industry and, vast presence of the various medical technology companies are attributed to the segment growth
• North America has dominated the clinical trial imaging market and is also expected to dominate the market during the forecast period.

Research Objectives of Clinical Trial Imaging Market Report:

• Analysing the outlook of the clinical trial imaging market with the recent trends and Porter’s five forces analysis
• Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period
• Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects
• Country-level analysis, integrating the demand and supply forces that are influencing the growth of the clinical trial imaging market
• Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years
• Comprehensive company profiles, covering the product offerings, key financial information, recent developments and strategies employed by the major market players

Buy this report @ https://www.axiommrc.com/buy_now/10398-clinical-trial-imaging-market-report 

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 700+ Market Research Projects, 2100+ Data Analytics Projects, 260+ Business Support Projects and has a 400+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data Analytics Company by providing key market intelligence solutions for client’s business growth.

For more information, visit Axiom Market Research & Consulting™ at www.axiommrc.com

Contact Us:

Axiom Market Research & Consulting

United States

3 Germay Dr.Ste 4 – 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com 

Website: https://www.axiommrc.com

Tags: Clinical Trial Imaging Market, Clinical trial Imaging, Clinical trial Imaging Market Size, Clinical trial Imaging Market Share, Clinical Trial Imaging Market Report, Clinical Trial Imaging Analysis